REFERENCES
151.
Malmberg K, Ryden L, Efendic S, et al: Randomized
trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic
patients with acute myocardial infarction (DIGAMI study): Effects on mortality at
1 year. J Am Coll Cardiol 26:57–65, 1995.
152.
van den Berghe G, Wouters P, Weekers F, et al:
Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367,
2001.
153.
Satomi N, Sakurai A, Haranaka K: Relationship
of hypoglycemia to tumor necrosis factor production and antitumor activity: Role
of glucose, insulin, and macrophages. J Natl Cancer Inst 74:1255–1260, 1985.
154.
Das UN: Is insulin an antiinflammatory molecule?
Nutrition 17:409–413, 2001.
155.
Van den Berghe G, Wouters PJ, Bouillon R, et al:
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose
versus glycemic control. Crit Care Med 31:359–366, 2003.
156.
Rabkin R, Simon NM, Steiner S, Colwell JA: Effect
of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 282:182–187,
1970.
157.
Finney SJ, Zekveld C, Elia A, Evans TW: Glucose
control and mortality in critically ill patients. JAMA 290:2041–2047, 2003.
158.
Evans TW: Hemodynamic and metabolic therapy in
critically ill patients. N Engl J Med 345:1417–1418, 2001.
159.
de Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw
WI, et al: Out-of-hospital cardiac arrest in the 1990's: A population-based study
in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol
30:1500–1505, 1997.
160.
Eisenberg MS, Horwood BT, Cummins RO, et al:
Cardiac arrest and resuscitation: A tale of 29 cities. Ann Emerg Med 19:179–186,
1990.
161.
Murphy DJ, Murray AM, Robinson BE, Campion EW:
Outcomes of cardiopulmonary resuscitation in the elderly. Ann Intern Med 111:199–205,
1989.
162.
Robinson GR 2nd, Hess D: Postdischarge survival
and functional status following in-hospital cardiopulmonary resuscitation. Chest
105:991–996, 1994.
163.
Negovsky VA: Postresuscitation disease. Crit
Care Med 16:942–946, 1988.
164.
Edgren E, Hedstrand U, Kelsey S, et al: Assessment
of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study
Group. Lancet 343:1055–1059, 1994.
165.
Oku K, Kuboyama K, Safar P, et al: Cerebral and
systemic arteriovenous oxygen monitoring after cardiac arrest: Inadequate cerebral
oxygen delivery. Resuscitation 27:141–152, 1994.
166.
Bernard S: Induced hypothermia in intensive care
medicine. Anaesth Intensive Care 24:382–388, 1996.
167.
Yanagawa Y, Ishihara S, Norio H, et al: Preliminary
clinical outcome study of mild resuscitative hypothermia after out-of-hospital cardiopulmonary
arrest. Resuscitation 39:61–66, 1998.
168.
Chopp M, Knight R, Tidwell CD, et al: The metabolic
effects of mild hypothermia on global cerebral ischemia and recirculation in the
cat: Comparison to normothermia and hyperthermia. J Cereb Blood Flow Metab 9:141–148,
1989.
169.
Dempsey RJ, Combs DJ, Maley ME, et al: Moderate
hypothermia reduces postischemic edema development and leukotriene production. Neurosurgery
21:177–181, 1987.
170.
Busto R, Globus MY, Dietrich WD, et al: Effect
of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty
acids in rat brain. Stroke 20:904–910, 1989.
171.
Mild therapeutic hypothermia to improve the neurologic
outcome after cardiac arrest. N Engl J Med 346:549–556, 2002.
172.
Bernard SA, Gray TW, Buist MD, et al: Treatment
of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.
N Engl J Med 346:557–563, 2002.
173.
Clifton GL, Miller ER, Choi SC, et al: Lack of
effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556–563,
2001.
174.
Ely EW, Bernard GR: Transfusions in critically
ill patients. N Engl J Med 340:467–468, 1999.
175.
Hebert PC, Wells G, Martin C, et al: A Canadian
survey of transfusion practices in critically ill patients. Transfusion Requirements
in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit
Care Med 26:482–487, 1998.
176.
Russell JA, Phang PT: The oxygen delivery/consumption
controversy. Approaches to management of the critically ill. Am J Respir Crit Care
Med 149:533–537, 1994.
177.
Bordin JO, Heddle NM, Blajchman MA: Biologic
effects of leukocytes present in transfused cellular blood products. Blood 84:1703–1721,
1994.
178.
van de Watering LM, Hermans J, Houbiers JG, et
al: Beneficial effects of leukocyte depletion of transfused blood on postoperative
complications in patients undergoing cardiac surgery: A randomized clinical trial.
Circulation 97:562–568, 1998.
179.
Langenfeld JE, Livingston DH, Machiedo GW: Red
cell deformability is an early indicator of infection. Surgery 110:398–403,
discussion 403–404, 1991.
180.
Busch MP, Kleinman SH, Nemo GJ: Current and emerging
infectious risks of blood transfusions. JAMA 289:959–962, 2003.
181.
Nucci ML, Abuchowski A: The search for blood
substitutes. Sci Am 278:72–77, 1998.
182.
Carson JL, Terrin ML, Barton FB, et al: A pilot
randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell
transfusions following hip fracture. Transfusion 38:522–529, 1998.
183.
Bracey AW, Radovancevic R, Riggs SA, et al: Lowering
the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect
on patient outcome. Transfusion 39:1070–1077, 1999.
184.
Lotke PA, Barth P, Garino JP, Cook EF: Predonated
autologous blood transfusions after total knee arthroplasty: Immediate versus delayed
administration. J Arthroplasty 14:647–650, 1999.
185.
Hebert PC, Wells G, Blajchman MA, et al: A multicenter,
randomized, controlled clinical trial of transfusion requirements in critical care.
Transfusion Requirements in Critical Care Investigators, Canadian Critical Care
Trials Group. N Engl J Med 340:409–417, 1999.
186.
Hebert PC, Yetisir E, Martin C, et al: Is a low
transfusion threshold safe in critically ill patients with cardiovascular diseases?
Crit Care Med 29:227–234, 2001.
187.
Wu WC, Rathore SS, Wang Y, et al: Blood transfusion
in elderly patients with acute myocardial infarction. N Engl J Med 345:1230–1236,
2001.
188.
Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion
in the ICU. Is there a reason? Chest 108:767–771, 1995.
189.
Rogiers P, Zhang H, Leeman M, et al: Erythropoietin
response is blunted in critically ill patients. Intensive Care Med 23:159–162,
1997.
190.
Gabriel A, Kozek S, Chiari A, et al: High-dose
recombinant human erythropoietin stimulates reticulocyte production in patients with
multiple organ dysfunction syndrome. J Trauma 44:361–367, 1998.
191.
Corwin HL, Gettinger A, Rodriguez RM, et al:
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized,
double-blind, placebo-controlled trial. Crit Care Med 27:2346–2350, 1999.
192.
Corwin HL, Gettinger A, Pearl RG, et al: Efficacy
of recombinant human erythropoietin in critically ill patients: A randomized controlled
trial. JAMA 288:2827–2835, 2002.
193.
Brown JJ, Sullivan G: Effect on ICU mortality
of a full-time critical care specialist. Chest 96:127–129, 1989.
194.
Baldock G, Foley P, Brett S: The impact of organisational
change on outcome in an intensive care unit in the United Kingdom. Intensive Care
Med 27:865–872, 2001.
195.
Kuo HS, Chuang JH, Tang GJ, et al: Development
of a new prognostic system and validation of APACHE II for surgical ICU mortality:
A multicenter study in Taiwan. Zhonghua Yi Xue Za Zhi 62:673–681, 1999.
196.
Al Asadl L, Dellinger R, Deutch J, Nathan S:
Clinical impact of closed versus open provider care in a medical intensive care unit.
Am J Respir Crit Care Med 153:A360, 1996.
197.
Manthous CA, Amoateng-Adjepong Y, al-Kharrat T,
et al: Effects of a medical intensivist on patient care in a community teaching
hospital. Mayo Clin Proc 72:391–399, 1997.
198.
Marini C, Nathan I, Ritter G, et al: The impact
of full-time surgical intensivists on ICU utilization and mortality. Crit Care Med
23:A235, 1995.
199.
Pollack MM, Katz RW, Ruttimann UE, Getson PR:
Improving the outcome and efficiency of intensive care: The impact of an intensivist.
Crit Care Med 16:11–17, 1988.
200.
Reich H, Buhler L, David M, Whitmer G: Saving
lives in the community: Impact of intensive care leadership. Crit Care Med 25:A44,
1998.
201.
DiCosmo B: Addition of an intensivist improves
ICU outcomes in a non-teaching community hospital. Chest 116:238S, 1999.
202.
Rosenfeld BA, Dorman T, Breslow MJ, et al: Intensive
care unit telemedicine: Alternate paradigm for providing continuous intensivist
care. Crit Care Med 28:3925–3931, 2000.
203.
Goh AY, Lum LC, Abdel-Latif ME: Impact of 24
hour critical care physician staffing on case-mix adjusted mortality in paediatric
intensive care. Lancet 357:445–446, 2001.
204.
Topeli A: Effect of changing organization of
intensive care unit from "open policy without critical care specialist" to "closed
policy with critical care specialist." Am J Respir Crit Care Med 161:A397, 2000.
205.
Orozco-Levi M, Torres A, Ferrer M, et al: Semirecumbent
position protects from pulmonary aspiration but not completely from gastroesophageal
reflux in mechanically ventilated patients. Am J Respir Crit Care Med 152:1387–1390,
1995.
206.
Torres A, Serra-Batlles J, Ros E, et al: Pulmonary
aspiration of gastric contents in patients receiving mechanical ventilation: The
effect of body position. Ann Intern Med 116:540–543, 1992.
207.
Messori A, Trippoli S, Vaiani M, et al: Bleeding
and pneumonia in intensive care patients given ranitidine and sucralfate for prevention
of stress ulcer: Meta-analysis of randomised controlled trials. BMJ 321:1103–1106,
2000.
208.
Tryba M, Cook DJ: Gastric alkalinization, pneumonia,
and systemic infections: The controversy. Scand J Gastroenterol Suppl 210:53–59,
1995.
209.
Cook DJ: Stress ulcer prophylaxis: Gastrointestinal
bleeding and nosocomial pneumonia. Best evidence synthesis. Scand J Gastroenterol
Suppl 210:48–52, 1995.
210.
Cook D, Guyatt G, Marshall J, et al: A comparison
of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding
in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
N Engl J Med 338:791–797, 1998.
211.
Maki DG, Ringer M, Alvarado CJ: Prospective randomised
trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection
associated with central venous and arterial catheters. Lancet 338:339–343,
1991.
212.
Sznajder JI, Zveibil FR, Bitterman H, et al:
Central vein catheterization: Failure and complication rates by three percutaneous
approaches. Arch Intern Med 146:259–261, 1986.
213.
Fares LG 2nd, Block PH, Feldman SD: Improved
house staff results with subclavian cannulation. Am Surg 52:108–111, 1986.
